Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR logo

Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR (HNGZY)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
4. 45
0
0%
$
6.86B Market Cap
- P/E Ratio
1.2% Div Yield
612 Volume
- Eps
$ 4.45
Previous Close
Add Transaction
Day Range
4.45 4.45
Year Range
4 4.45
Want to track HNGZY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR logo
HNGZY Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR
28 Apr 2026
-
-
Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR logo
HNGZY Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR
27 Mar 2026
-
-
Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR logo
HNGZY Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR
25 Oct 2024
-
-
Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR logo
HNGZY Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR
23 Aug 2024
-
-

HNGZY Earnings Reports FAQ

What is the earnings per share (EPS) for HNGZY?

EPS data for HNGZY is currently not available, as Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR has not reported recent earnings.

What is the company's earnings growth rate?

Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for HNGZY at this time, as Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR has no recent EPS data to calculate it.